Connect to other sites within the UBM Medica Network
H. Pylori Might Curb MS Risk in Women
A new study indicates that infection with Helicobacter pylori might lower the risk of multiple sclerosis, at least in women. Pharmaceutical products could provide a novel means of treatment.
Stratifying PML Risk in Multiple Sclerosis
The risk of progressive multifocal leukoencephalopathy in patients receiving Tysabri for MS is a concern about this otherwise extremely effective therapy.
Immunosuppression, Stem Cells Halt MS
HDIT/HCT could induce sustained remission and neurological improvements in patients with multiple sclerosis.
New Concept in MS: NEDA
No evidence of disease activity (NEDA) is a new concept developing in MS. The field is beginning to ask how well the new treatments are doing and whether can we ultimately shut down the disease.
Brainpower Answers Burning Questions in Neurology
Get to the root of the latest research findings on nervous system disorders and test your brainpower with this quick 5-question quiz.
Multiple Sclerosis Drug Lemtrada Gets FDA Nod
Approved for patients with relapsing forms of MS, the drug generally should be reserved for those who have had an inadequate response to 2 or more drugs indicated for MS treatment.
What MS Therapies Patients Want
As more treatments become available, patients will have more preferences and will play a more prominent role in directing choices.
Earn CME Credits for reading Psychiatric Times articles. Click here to go to our free online CME activities.
By clicking Accept, you agree to become a member of the UBM Medica Community.